Company Info
Phone(636) 385-5306
Year Established
2018
Contacts
Kumar Srinivasan Ph.D., M.B.APresident & CEO
Ayman Kabakibi, Ph.D.
COO & Executive VP, R&D
Keith Vendola, M.D., MBA
CFO
Jim Faulkner, Ph.D.
CTO
Mark Lewis, Ph.D.
VP, Finance & Business Operations
Company Description
Wugen is a clinical-stage biotechnology company developing a pipeline of allogeneic cell therapies to treat a broad range of hematological and solid tumor malignancies.
